We are live on ! Find out more
DY

Dowling & Yahnke Portfolio holdings

AUM $2.15B
1-Year Est. Return 10.82%
This Fund
S&P 500
This Quarter Est. Return
-0.2%
1 Year Est. Return
-10.82%
3 Year Est. Return
+34.82%
5 Year Est. Return
+71.23%
10 Year Est. Return
AUM
$795M
AUM Growth
-$5M
Cap. Flow
-$111K
Cap. Flow %
-0.01%
Top 10 Hldgs %
25.95%
Holding
272
New
16
Increased
102
Reduced
113
Closed
8

Top Buys

Rank Stock Value
1
EVH icon
Evolent Health
EVH
+$559K
2
AGN
Allergan Inc
AGN
+$512K
3
DXCM icon
DexCom
DXCM
+$454K
4
KO icon
Coca-Cola
KO
+$405K
5
VGK icon
Vanguard FTSE Europe ETF
VGK
+$370K

Sector Composition

Rank Sector Weight
1 Miscellaneous 20.84%
2 Healthcare 16.35%
3 Consumer Staples 12.39%
4 Technology 11.78%
5 Financials 11.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ESRX
101
DELISTED
Express Scripts Holding Company
ESRX
$2.49M 0.31%
28,031
-376
-1% -$32.8K
OXY icon
102
Occidental Petroleum
OXY
$59.1B
$2.45M 0.31%
31,615
-228
-0.7% -$17.8K
NKE icon
103
Nike
NKE
$58.7B
$2.44M 0.31%
45,264
+1,428
+3% +$73.2K
PSX icon
104
Phillips 66
PSX
$97.4B
$2.32M 0.29%
28,756
-14
-0% -$1.11K
BA icon
105
Boeing
BA
$166B
$2.27M 0.29%
16,369
+801
+5% +$117K
ITW icon
106
Illinois Tool Works
ITW
$79.8B
$2.25M 0.28%
24,459
+822
+3% +$78.2K
VO icon
107
Vanguard Morningstar Mid-Cap ETF
VO
$109B
$2.22M 0.28%
69,656
+3,016
+5% +$97.9K
STT icon
108
State Street
STT
$53.1B
$2.18M 0.27%
28,369
+400
+1% +$31.1K
ACN icon
109
Accenture
ACN
$116B
$2.18M 0.27%
22,510
+840
+4% +$80.3K
EFG icon
110
iShares MSCI EAFE Growth ETF
EFG
$17.1B
$2.17M 0.27%
31,029
-520
-2% -$37.8K
CELG
111
DELISTED
Celgene Corp
CELG
$2.12M 0.27%
18,273
-438
-2% -$50.1K
IDU icon
112
iShares US Utilities ETF
IDU
$1.31B
$2.11M 0.27%
40,732
-474
-1% -$26.1K
VEA icon
113
Vanguard FTSE Developed Markets ETF
VEA
$238B
$2.11M 0.27%
53,243
+2,851
+6% +$118K
VDE icon
114
Vanguard Energy ETF
VDE
$10.7B
$2.08M 0.26%
19,482
-620
-3% -$69.7K
XES icon
115
State Street SPDR S&P Oil & Gas Equipment & Services ETF
XES
$385M
$2.02M 0.25%
7,741
+413
+6% +$116K
UI icon
116
Ubiquiti
UI
$36.3B
$2.01M 0.25%
62,920
-100
-0.2% -$3.08K
TFCFA
117
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
$1.85M 0.23%
56,926
+3,366
+6% +$113K
EOG icon
118
EOG Resources
EOG
$75.2B
$1.8M 0.23%
20,547
+297
+1% +$27.4K
IYZ icon
119
iShares US Telecommunications ETF
IYZ
$1.28B
$1.76M 0.22%
60,288
-1,094
-2% -$33.3K
JCI icon
120
Johnson Controls International
JCI
$84.6B
$1.75M 0.22%
33,840
+1,897
+6% +$102K
AFL icon
121
Aflac
AFL
$58.4B
$1.75M 0.22%
56,338
-52
-0.1% -$1.65K
HPQ icon
122
HP
HPQ
$27.5B
$1.74M 0.22%
127,505
+6,866
+6% +$102K
PNC icon
123
PNC Financial Services
PNC
$96.6B
$1.73M 0.22%
18,110
+417
+2% +$39.4K
IWM icon
124
iShares Russell 2000 ETF
IWM
$80.8B
$1.73M 0.22%
13,843
-307
-2% -$38.4K
VTI icon
125
Vanguard Morningstar Total Stock Market ETF
VTI
$687B
$1.68M 0.21%
15,683
+525
+3% +$57.3K

Similar funds

Dowling & Yahnke's Q2 2015 Portfolio in Review

As of Q2 2015, Dowling & Yahnke held 272 positions worth $795M, down 0.63% from $800M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Dowling & Yahnke's Q2 2015 filing shows 16 new, 102 increased, 113 reduced and 8 closed positions. Its largest new stake was Evolent Health: 30,000 shares worth $585K. The largest sale was Interactive Brokers, an estimated $1.11M.

By sector, the portfolio is most concentrated in Miscellaneous at 21% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Dowling & Yahnke's largest Q2 2015 buy was Evolent Health: 30,000 shares worth $585K.
  • Dowling & Yahnke added most to DexCom in Q2 2015, an estimated $454K increase.
  • Dowling & Yahnke's biggest Q2 2015 reduction was Reliance Steel & Aluminium, cutting an estimated $1.04M.
  • Dowling & Yahnke fully exited Interactive Brokers in Q2 2015, selling an estimated $1.11M.
  • Dowling & Yahnke's ten largest holdings make up 26% of its $795M portfolio in Q2 2015.
  • Dowling & Yahnke opened 16 new positions and closed 8 in Q2 2015.
  • Dowling & Yahnke's portfolio value fell 0.63% quarter-over-quarter to $795M.

Based on Dowling & Yahnke's 13F filing for Q2 2015, filed 22 Jul 2015.